Literature DB >> 1997384

A pooling strategy for heterozygote screening of the delta F508 cystic fibrosis mutation.

C Gille1, K Grade, C Coutelle.   

Abstract

A theoretical and practical approach to economize the analysis of large DNA sample numbers for identifying heterozygosity of the delta F508 mutation causing cystic fibrosis is presented. Sample pooling can reduce the number of polymerase chain reaction (PCR) tests for this mutation by up to 77%. Based on a mathematical model, the optimal number (n) of samples to be united in one pool is 24 for a German population with a delta F508 heterozygosity incidence of about 1/35. We show that the PCR method is sufficient to detect one heterozygote for the delta F508 mutation in a pool of up to 49 non-delated DNA samples.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997384     DOI: 10.1007/bf00202411

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

2.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).

Authors:  C R Newton; A Graham; L E Heptinstall; S J Powell; C Summers; N Kalsheker; J C Smith; A F Markham
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

3.  Frequency of the F508 deletion in the CFTR gene in Turkish cystic fibrosis patients.

Authors:  J Hundrieser; S Bremer; F Peinemann; M Stuhrmann; N Hoffknecht; B Wulf; J Schmidtke; J Reiss; G Maass; B Tümmler
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

4.  Distribution patterns of the delta F508 mutation in the CFTR gene of CF-linked marker haplotypes in the German population.

Authors:  A Reis; S Bremer; M Schlösser; M Dueck; I Böhm; J Hundrieser; M Macek; M Stuhrmann; M Wagner; T Dörk
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

5.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

6.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  First analysis of the F508 deletion in cystic fibrosis patients from the GDR.

Authors:  K Grade; K Will; R Szibor; J Gedschold; R Brückner; I Bauer; K Giermann; H Gorki; J Hein; U Brell
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

  7 in total
  2 in total

1.  Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.

Authors:  U Jung; U Urner; K Grade; C Coutelle
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

2.  Utilities for high throughput use of the single strand conformational polymorphism method: screening of 791 patients with familial hypercholesterolaemia for mutations in exon 3 of the low density lipoprotein receptor gene.

Authors:  R Whittall; V Gudnason; G P Weavind; L B Day; S E Humphries; I N Day
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.